arrow
J

Ja-Lok Ku

seoul national university college of medicine
H指数:39
被引数:4,367

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer

ESRP1调控的DNMT3B异构体转换决定了胰腺癌的恶性潜能

2026-07-100
PRE
Ferroptosis-based therapeutic strategy targeting iron metabolism and SLC7A11 overcomes oxaliplatin resistance in patient-derived pancreatic cancer organoids

基于铁死亡的靶向铁代谢和SLC7A11的治疗策略克服患者源性胰腺癌类器官中的奥沙利铂耐药性

2026-05-300
OA
Correction: Proteogenomic characterization of molecular and cellular targets for treatment‑resistant subtypes in locally advanced cervical cancers

更正: 局部晚期宫颈癌中治疗耐药亚型的分子和细胞靶标的蛋白质基因组学特征

2025-11-290
OAAI
Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models

建立和表征24种乳腺癌细胞系和3种乳腺癌类器官,揭示恶性胸腔积液衍生的模型中的分子异质性和药物反应可变性

2025-05-010
OA
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers

局部晚期宫颈癌治疗抵抗亚型的分子和细胞靶点的蛋白质组学表征

2025-03-141
OA
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes (vol 4, pg 290, 2023)
2023-05-191
OA
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes
2022-12-2215
PRE